144 related articles for article (PubMed ID: 8112979)
1. Photoreceptor cell tumors in transgenic mice.
Howes KA; Lasudry JG; Albert DM; Windle JJ
Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):342-51. PubMed ID: 8112979
[TBL] [Abstract][Full Text] [Related]
2. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen.
Marcus DM; Lasudry JG; Carpenter JL; Windle J; Howes KA; al-Ubaidi MR; Baehr W; Overbeek PA; Font RL; Albert DM
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):392-6. PubMed ID: 8603844
[TBL] [Abstract][Full Text] [Related]
3. Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma.
Marcus DM; Carpenter JL; O'Brien JM; Kivela T; Brauner E; Tarkkanen A; Virtanen I; Albert DM
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):293-301. PubMed ID: 1993580
[TBL] [Abstract][Full Text] [Related]
4. Expression of retina-specific genes by mouse retinoblastoma cells.
Bernstein SL; Kutty G; Wiggert B; Albert DM; Nickerson JM
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3931-7. PubMed ID: 7928191
[TBL] [Abstract][Full Text] [Related]
5. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
Vooijs M; te Riele H; van der Valk M; Berns A
Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
[TBL] [Abstract][Full Text] [Related]
6. Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice.
Fung KM; Chikaraishi DM; Suri C; Theuring F; Messing A; Albert DM; Lee VM; Trojanowski JQ
Lab Invest; 1994 Jan; 70(1):114-24. PubMed ID: 7508007
[TBL] [Abstract][Full Text] [Related]
7. Trilateral retinoblastoma: ocular and pineal retinoblastomas.
Johnson DL; Chandra R; Fisher WS; Hammock MK; McKeown CA
J Neurosurg; 1985 Sep; 63(3):367-70. PubMed ID: 4020463
[TBL] [Abstract][Full Text] [Related]
8. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
[TBL] [Abstract][Full Text] [Related]
9. A transgenic mouse model for trilateral retinoblastoma.
O'Brien JM; Marcus DM; Bernards R; Carpenter JL; Windle JJ; Mellon P; Albert DM
Arch Ophthalmol; 1990 Aug; 108(8):1145-51. PubMed ID: 1696469
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM
Cell Growth Differ; 1995 Dec; 6(12):1591-600. PubMed ID: 9019164
[TBL] [Abstract][Full Text] [Related]
11. Trilateral retinoblastoma in transgenic mice.
O'Brien JM; Marcus DM; Niffenegger AS; Bernards R; Carpenter JL; Windle JJ; Mellon P; Albert DM
Trans Am Ophthalmol Soc; 1989; 87():301-22; discussion 322-6. PubMed ID: 2576479
[No Abstract] [Full Text] [Related]
12. Transgenic models of retinoblastoma: what they tell us about its cause and treatment.
Albert DM; Griep AE; Lambert PF; Howes KA; Windle JJ; Lasudry JG
Trans Am Ophthalmol Soc; 1994; 92():385-400; discussion 400-1. PubMed ID: 7886874
[No Abstract] [Full Text] [Related]
13. Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.
Joseph RM; Li T
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2434-46. PubMed ID: 8933760
[TBL] [Abstract][Full Text] [Related]
14. Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma.
Gonzalez-Fernandez F; Lopes MB; Garcia-Fernandez JM; Foster RG; De Grip WJ; Rosemberg S; Newman SA; VandenBerg SR
Am J Pathol; 1992 Aug; 141(2):363-75. PubMed ID: 1386715
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.
Howes KA; Ransom N; Papermaster DS; Lasudry JG; Albert DM; Windle JJ
Genes Dev; 1994 Jun; 8(11):1300-10. PubMed ID: 7986270
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.
Syed NA; Windle JJ; Darjatmoko SR; Lokken JM; Steeves RA; Chappell R; Wallow IH; Koop BA; Mangold G; Howes KA; Albert DM
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2800-5. PubMed ID: 9856795
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter.
Chiu IM; Touhalisky K; Liu Y; Yates A; Frostholm A
Oncogene; 2000 Dec; 19(54):6229-39. PubMed ID: 11175337
[TBL] [Abstract][Full Text] [Related]
18. Progressive and regressive fate of lens tumors correlates with subtle differences in transgene expression in gamma F-crystallin-SV40 T antigen transgenic mice.
Bryce DM; Liu Q; Khoo W; Tsui LC; Breitman ML
Oncogene; 1993 Jun; 8(6):1611-20. PubMed ID: 8389033
[TBL] [Abstract][Full Text] [Related]
19. Treatment of spontaneously arising retinoblastoma tumors in transgenic mice with an attenuated herpes simplex virus mutant.
Brandt CR; Imesch PD; Robinson NL; Syed NA; Untawale S; Darjatmoko SR; Chappell RJ; Heinzelman P; Albert DM
Virology; 1997 Mar; 229(1):283-91. PubMed ID: 9123872
[TBL] [Abstract][Full Text] [Related]
20. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
